Xarelto (Rivaroxaban) Dosing Calculator: Complete Clinical Guide for Physicians
Introduction
The rivaroxaban (Xarelto) is one of the most widely used direct oral anticoagulants (DOACs) in clinical practice. Its efficacy, once-daily dosing and safety profile make it a solid alternative to vitamin K antagonists.
However, the rivaroxaban dose must be carefully individualised. Factors such as kidney function, age, weight and clinical indication determine the optimal regimen.
In this guide we review how to calculate the Xarelto dose in the different indications, the renal adjustment criteria and special cases that require caution.
RIVAROXABAN (XARELTO®) — Dose calculator
Base dose 20 mg once daily. Adjustments for kidney function and contraindications according to reference tables.
1) Indication
2) Patient data
3) Interactions and comorbidity
RESULT
If you prefer, in this other calculator you can compare the different direct oral anticoagulants.
What Is Rivaroxaban (Xarelto)?
The rivaroxaban is a direct inhibitor of factor Xa, which blocks thrombin generation and fibrin formation.
It is given taken orally, it has a half-life of 5 to 13 hours (longer in older people) and is absorbed better with food, especially at the 15 mg and 20 mg doses.
The most common brand name is Xarelto, available as tablets of 2.5 mg, 10 mg, 15 mg and 20 mg.
Its elimination is approximately 66% renal and 33% hepatic, so kidney function must be assessed before and during treatment.
Main Indications
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
- Treatment and prevention of venous thromboembolism (VTE): deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of postoperative venous thrombosis after major orthopaedic surgery.
- Secondary prevention of cardiovascular events in coronary or peripheral artery disease (low doses combined with aspirin).
Standard Dose of Rivaroxaban (Xarelto)
1. Non-valvular atrial fibrillation
- Standard dose: 20 mg once daily, with the evening meal.
- If creatinine clearance (CrCl) is 15–49 ml/min: 15 mg once daily.
- Not recommended if CrCl < 15 ml/min.
2. Venous thromboembolism (DVT / PE)
- Initial treatment: 15 mg every 12 hours for 21 days.
- Maintenance phase: 20 mg once daily.
- In patients at high bleeding risk or with moderate renal impairment, consider 15 mg dailyafter the initial phase.
3. VTE prevention after orthopaedic surgery
- 10 mg once daily, starting 6 to 10 hours after surgery (if haemostasis is adequate).
- Duration:
- Hip surgery → 35 days.
- Knee surgery → 14 days.
- Duration:
4. Stable peripheral or coronary artery disease
- 2.5 mg every 12 hours combined with aspirin (75–100 mg daily).
Dose Adjustment by Kidney Function
Kidney function has a significant influence on the plasma concentration of rivaroxaban.
| Creatinine clearance (ml/min) | Recommended dose |
|---|---|
| ≥ 50 | Standard dose according to indication |
| 30–49 | Reduce dose (15 mg/day in AF or VTE maintenance) |
| 15–29 | Use with caution; 15 mg/day maximum |
| < 15 | Not recommended / contraindicated |
Practical tip: recalculate creatinine clearance in older people or if there are clinical changes (dehydration, acute kidney injury, loss of muscle mass).
Adjustment for Age, Weight and Bleeding Risk
- Over 75–80 years: higher risk of bleeding, but the dose is not reduced for age, only for kidney function.
- Extreme body weight (< 50 kg or > 120 kg): monitor efficacy and safety, although there is no formal adjustment.
- High bleeding risk: consider alternatives or temporary reduction depending on the clinical situation.
The balance between thrombotic and bleeding risk should always guide the final decision.
Drug Interactions
The rivaroxaban (Xarelto) is a substrate of P-glycoprotein (P-gp) y CYP3A4, so significant interactions can alter its plasma levels.
Potent inhibitors (increase levels):
- Ketoconazole
- Itraconazole
- Ritonavir
- Clarithromycin
- Verapamil
Strong inducers (decrease levels):
- Rifampicin
- Phenytoin
- Carbamazepine
- St John's wort
Avoid concomitant use with other anticoagulants or antiplatelets unless there is a specific indication and under close monitoring.
Clinical Examples of Dose Calculation
Example 1:
65-year-old man with non-valvular AF and clearance 85 ml/min →
✅ Dose: 20 mg once daily with the evening meal.
Example 2:
78-year-old woman with AF and clearance 40 ml/min →
✅ Dose: 15 mg once daily with the evening meal.
Example 3:
Patient with acute DVT, normal kidney function →
✅ Dose: 15 mg every 12 h for 21 days, then 20 mg once daily.
Example 4:
Man with stable peripheral artery disease →
✅ Dose: 2.5 mg every 12 h + aspirin 100 mg/day.
How to Use the Rivaroxaban (Xarelto) Dose Calculator
The calculator is at the top of the article. To get the rivaroxaban dose:
- Choose the indication: non-valvular atrial fibrillation, treatment of DVT/PE or secondary prevention.
- Enter the creatinine clearance of the patient.
- Tick the interactions and comorbidities: azole antifungals or HIV protease inhibitors, and Child-Pugh B or C liver failure.
- Check the result: the "Result" box shows the recommended dose and the criterion behind it.
The tool is a guide only: it does not replace individual clinical assessment or the drug's prescribing information.
Precautions and Practical Tips
- Give the 15 mg and 20 mg doses always with food.
- Check kidney function before starting and at least once a year.
- Stop treatment 24–48 h before surgery (depending on risk and kidney function).
- Restart as soon as haemostasis is restored.
- Avoid unjustified interruptions of treatment (they increase thrombotic risk).
Conclusion
The rivaroxaban (Xarelto) dose must be carefully personalised according to the indication, kidney function and the patient's clinical profile.
The simplified regimen (one daily dose in most cases) helps adherence, but requires a correct initial assessment to ensure efficacy and safety.





